Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support

Percutaneous closure may be considered when there is cryptogenic ischemic stroke or transient ischemic attack (TIA) assessed to be related to patent foramen ovale (PFO), and the shunt volume or anatomy is considered high risk. The decision is based on a comprehensive assessment of age, stroke etiolo
24-72h
Response window
Approx. $5,400
Treatment fee
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Let us coordinate the treatment journey with you.
Percutaneous closure is typically performed via the femoral vein approach, crossing the foramen ovale under fluoroscopic and transesophageal or intracardiac echocardiographic guidance. The channel is measured, and an occluder (such as a double-disc device) is selected and deployed after confirming its position and stability. Residual shunting is then checked. After the procedure, the sheath is removed, hemostasis is achieved, and heart rhythm and the puncture site are monitored. Ultrasound is used to assess device apposition, with the goal of blocking paradoxical embolism pathways. The above is general health information, not medical advice; specific details should be based on specialist evaluation and hospital protocols.
Percutaneous closure is typically performed via the femoral vein approach, crossing the foramen ovale under fluoroscopic and transesophageal or intracardiac echocardiographic guidance. The channel is measured, and an occluder (such as a double-disc device) is selected and deployed after confirming its position and stability. Residual shunting is then checked. After the procedure, the sheath is removed, hemostasis is achieved, and heart rhythm and the puncture site are monitored. Ultrasound is used to assess device apposition, with the goal of blocking paradoxical embolism pathways. The above is general health information, not medical advice; specific details should be based on specialist evaluation and hospital protocols.

Combining "preoperative assessment + hospitalization/treatment + postoperative follow-up", it is recommended to stay in China for approximately 7–14 days in total; the specific itinerary and return time are subject to the actual arrangements of the hospital and individual recovery.

Tell us about your Patent Foramen Ovale case and we will help match you with the right hospital, specialist, and travel pathway.